Literature DB >> 14005034

Concentrated inactivated measlesvirus vaccine. Preparation and antigenic potency.

J WARREN, M J GALLIAN.   

Abstract

Keywords:  MEASLES/immunology

Mesh:

Substances:

Year:  1962        PMID: 14005034

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


× No keyword cloud information.
  9 in total

Review 1.  MEASLES IMMUNIZATION.

Authors:  H A FELDMAN
Journal:  Bacteriol Rev       Date:  1964-12

2.  VACCINATION AGAINST MEASLES: A STUDY OF CLINICAL REACTIONS AND SEROLOGICAL RESPONSES OF YOUNG CHILDREN. A REPORT TO THE MEDICAL COUNCIL BY THE MEASLES VACCINES COMMITTEE.

Authors:  E NORRBY; R LAGERCRANTZ; S GARD
Journal:  Br Med J       Date:  1965-03-27

3.  INACTIVATED MEASLES-VIRUS VACCINE.

Authors:  W H FOEGE; O S LELAND; C S MOLLOHAN; V A FULGINITI; D A HENDERSON; C H KEMPE
Journal:  Public Health Rep       Date:  1965-01       Impact factor: 2.792

4.  IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.

Authors:  S GARD; G CARLSTROEM; R LAGERCRANTZ; E NORRBY
Journal:  Arch Gesamte Virusforsch       Date:  1965

5.  A collaborative study of measles vaccines in five United States communities. Preliminary report.

Authors:  V F GUINEE
Journal:  Am J Public Health Nations Health       Date:  1963-04

6.  Inactivated Measles Virus Vaccine.

Authors: 
Journal:  Br Med J       Date:  1962-06-23

7.  Vaccination against measles.

Authors: 
Journal:  Br Med J       Date:  1966-02-19

8.  CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.

Authors:  D R MACLEOD
Journal:  Can Med Assoc J       Date:  1964-11-21       Impact factor: 8.262

9.  PLAQUE DIFFERENTIATION AND REPLICATION OF VIRULENT AND ATTENUATED STRAINS OF MEASLES VIRUS.

Authors:  F RAPP
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.